Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06267859 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Development of Methods for Effective Treatment and Improvement of Common Somatic Diseases in Children

StatusEnrolling by Invitation
PhaseEarly Phase 1
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Enrollment increased: 110 → 600 participantsv5 Show 5 more changesShow less
    • Primary completion moved earlier from Dec 30, 2033 to Jan 30, 2032
    • Trial status changed: Recruiting → Enrolling by Invitation
    • Study description expanded, about 38 words
    • Site details revised
    • Eligibility criteria expanded, about 5 words
  2. Minor 2 versions Re-verified since Apr 23, 2025, no change to tracked fieldsv3-v4
  3. Notable Primary endpoints revised (4)
    • Study description expanded, about 40 words
    v2
  4. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of the clinical study is to clarify the course of common congenital, infectious, and non-infectious diseases in children living in Uzbekistan, and to develop methods for their treatment and rehabilitation. The main questions it aims to answer: * Analysis of common congenital diseases among children; * Analysis of the most frequently diagnosed bronchopulmonary (acute bronchitis with and without obstruction, congenital pneumonia, acute and chronic pneumonia) and cardiovascular diseases in children; * Based on the results of the primary research, common diseases among children will be identified; * Analysis of existing treatment methods and their effectiveness; * Development of modern methods of treatment and rehabilitation of children.
Trial Details
NCT Number NCT06267859
Lead Sponsor Tashkent State Medical University (Tashkent Pediatric Medical Institute), Uzbekistan
Conditions
(from sponsor)
Respiratory Diseases, Congenital Heart Defects
Related terms Bronchitis, Congenital Abnormalities, Heart Defects, Congenital, Heart Diseases, Lung Diseases, Respiratory Tract Diseases
Enrollment 600 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov